Alternate AChE-R variants facilitate cellular metabolic activity and resistance to genotoxic stress through enolase and RACK1 interactions.

[1]  H. Soreq,et al.  Acetylcholinesterase-R increases germ cell apoptosis but enhances sperm motility , 2008, Journal of cellular and molecular medicine.

[2]  B. Hochner,et al.  Peripheral Site Acetylcholinesterase Blockade Induces RACK1-Associated Neuronal Remodeling , 2007, Neurodegenerative Diseases.

[3]  Hermona Soreq,et al.  The thymic theme of acetylcholinesterase splice variants in myasthenia gravis. , 2007, Blood.

[4]  Y. Ben-Shaul,et al.  Acetylcholinesterase/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia , 2007, Leukemia.

[5]  I. Perlman,et al.  A novel isoform of acetylcholinesterase exacerbates photoreceptors death after photic stress. , 2007, Investigative ophthalmology & visual science.

[6]  I Jurisica,et al.  Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression , 2007, Oncogene.

[7]  R. Shaw,et al.  Glucose metabolism and cancer. , 2006, Current opinion in cell biology.

[8]  P. Coates.  Regulating p73 isoforms in human tumours , 2006, The Journal of pathology.

[9]  H. Pelicano,et al.  Glycolysis inhibition for anticancer treatment , 2006, Oncogene.

[10]  H. Soreq,et al.  Stress-induced cholinergic signaling promotes inflammation-associated thrombopoiesis. , 2006, Blood.

[11]  Alan Horwich,et al.  Testicular germ-cell cancer , 2006, The Lancet.

[12]  H. Soreq,et al.  RACK1 has the nerve to act: Structure meets function in the nervous system , 2006, Progress in Neurobiology.

[13]  C. J. Vidal.  Expression of cholinesterases in brain and non-brain tumours. , 2005, Chemico-biological interactions.

[14]  D. Tong,et al.  Clinical Relevance of Dominant-Negative p73 Isoforms for Responsiveness to Chemotherapy and Survival in Ovarian Cancer: Evidence for a Crucial p53-p73 Cross-talk In vivo , 2005, Clinical Cancer Research.

[15]  Z. Saifudeen,et al.  Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression. , 2005, The Journal of biological chemistry.

[16]  P. Tompa.  The interplay between structure and function in intrinsically unstructured proteins , 2005, FEBS letters.

[17]  H. Leffers,et al.  Genomic and gene expression signature of the pre-invasive testicular carcinoma in situ , 2005, Cell and Tissue Research.

[18]  S. Schreiber,et al.  Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[20]  K. Greulich,et al.  Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. , 2004, Genomics.

[21]  M. Matsuzaki,et al.  ERK1/2 Regulates Intracellular ATP Levels through α-Enolase Expression in Cardiomyocytes Exposed to Ischemic Hypoxia and Reoxygenation* , 2004, Journal of Biological Chemistry.

[22]  J. Sussman,et al.  The synaptic acetylcholinesterase tetramer assembles around a polyproline II helix , 2004, The EMBO journal.

[23]  P. Layer,et al.  Mouse acetylcholinesterase interacts in yeast with the extracellular matrix component laminin‐1β , 2004, FEBS letters.

[24]  V. Mamidipudi,et al.  RACK1 Regulates G1/S Progression by Suppressing Src Kinase Activity , 2004, Molecular and Cellular Biology.

[25]  F. Tronche,et al.  Combinatorial Complexity of 5′ Alternative Acetylcholinesterase Transcripts and Protein Products*[boxs] , 2004, Journal of Biological Chemistry.

[26]  U. Moll,et al.  p63 and p73: roles in development and tumor formation. , 2004, Molecular cancer research : MCR.

[27]  S. Moore,et al.  Identification of a structural site on acetylcholinesterase that promotes neurite outgrowth and binds laminin-1 and collagen IV. , 2004, Biochemical and biophysical research communications.

[28]  T. Golub,et al.  mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways , 2004, Nature Medicine.

[29]  H. Soreq,et al.  CREB regulates AChE-R-induced proliferation of human glioblastoma cells. , 2004, Neoplasia.

[30]  Y. Yoo,et al.  Acetylcholinesterase plays a pivotal role in apoptosome formation. , 2004, Cancer research.

[31]  R. Poon,et al.  How Many Mutant p53 Molecules Are Needed To Inactivate a Tetramer? , 2004, Molecular and Cellular Biology.

[32]  Z. Siddik,et al.  Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.

[33]  A. Nakagawara,et al.  Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells. , 2003, Cancer letters.

[34]  A. Nakagawara,et al.  Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB , 2003, Oncogene.

[35]  H. Soreq,et al.  Interaction of “readthrough” acetylcholinesterase with RACK1 and PKCβII correlates with intensified fear-induced conflict behavior , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Warwicker,et al.  The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. , 2002, Molecular pharmacology.

[37]  Y. Hemo,et al.  The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34(+) hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation. , 2002, Experimental hematology.

[38]  G. Tonini,et al.  Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients , 2002, Cell Death and Differentiation.

[39]  M. Shapira,et al.  ARP, A Peptide Derived from the Stress-Associated Acetylcholinesterase Variant, Has Hematopoietic Growth Promoting Activities , 2001, Molecular medicine.

[40]  J. Patrick,et al.  Excess "read-through" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Semenza,et al.  Oncogenic alterations of metabolism. , 1999, Trends in biochemical sciences.

[42]  F. Gros,et al.  Biochemical characterization of the mouse muscle-specific enolase: developmental changes in electrophoretic variants and selective binding to other proteins. , 1997, The Biochemical journal.

[43]  H. Farber,et al.  Non-neuronal Enolase Is an Endothelial Hypoxic Stress Protein (*) , 1995, The Journal of Biological Chemistry.

[44]  B. No̸rgaard-Pedersen,et al.  Overexpressed Monomeric Human Acetylcholinesterase Induces Subtle Ultrastructural Modifications in Developing Neuromuscular Junctions of Xenopus laevis Embryos , 1994, Journal of neurochemistry.

[45]  F. Clementi,et al.  Expression of three alternative acetylcholinesterase messenger RNAs in human tumor cell lines of different tissue origins. , 1994, Experimental cell research.

[46]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[47]  Lei Yang,et al.  Induction of acetylcholinesterase expression during apoptosis in various cell types , 2002, Cell Death and Differentiation.